Latest Uric acid Stories
SAN DIEGO, Nov. 8, 2010 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced positive results from two clinical studies of RDEA594 in combination with currently marketed drugs for the treatment of gout patients, febuxostat (UloricÂ®) and allopurinol.
CAMBRIDGE, Mass., Nov. 5, 2010 /PRNewswire/ -- Sermo (http://www.sermo.com), the world's largest online community for physicians, today announced a free Sermo Report titled, "Treatment Options for Gout".
EXTON, Pa., Oct. 14 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the recent release of a syndicated report focused on the management and treatment of gout in the US.
EAST BRUNSWICK, N.J., Sept. 14 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the U.S.
SILVER SPRING, Md., Sept. 14 /PRNewswire-USNewswire/ -- The U.S.
ATLANTA and DEERFIELD, Ill., Sept. 13 /PRNewswire/ -- The Arthritis Foundation and Takeda Pharmaceuticals North America, Inc., today announced the launch of a new educational campaign, Gout Living, to help increase understanding and encourage better management of gout.
ROME, June 18 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc.
Allopurinol helps kidney function and cuts heart risks.
WASHINGTON, June 10 /PRNewswire/ -- The 2010 Gout Attitudes Patient Survey (GAPS), a new study of Americans with gout, released today by Men's Health Network (MHN), sheds light on the painful reality of what life is like for the approximately five million Americans who live with this condition.
TARRYTOWN, N.Y., June 9 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.